A 2025 systematic review by Vasireddi and colleagues in HSS Journal screened 544 published papers and identified 36 meeting inclusion criteria 35 preclinical studies and only one human study: an uncontrolled, unblinded, retrospective case series of 12 patients receiving intra-articular BPC-157 for chronic knee pain, in which 7 of 12 (58%) reported self-described relief lasting more than 6 months, with no dose, effect size, or systematically collected adverse events published
Responsible innovation will ultimately determine how sustainably the GLP-1 market evolves
Pros Weight-loss-focused platform Convenient online enrollment Physician oversight Cons Fewer broader wellness services Program availability may differ by location Who Its Best For People primarily interested in weight management programs Patients new to telehealth 5
It is an important contributor to cellular energy metabolism
The FDA-designated label for cyanocobalamin states that it can be given either intramuscularly or subcutaneously
Whitfield answers your questions